—MNST
— • —
$75.72
P/E
39.12
PEG
0.01
FCF Yield
—
Rev Growth YoY
+1070.0% YoY
Gross Margin
5585.0%
Health Score
6/10
D/E Ratio
—
Confidence
LOW
Business Snapshot
The ticker and company name are not identified in the data payload, and sector/industry classification is absent. Based on available financial data, this appears to be a micro or small-cap company exhibiting early-stage hypergrowth characteristics. The stock is currently priced at $75.72, with market capitalisation data unavailable for precise size classification.
Financial Health
**Score: 6/10** The balance sheet is notably clean, with a debt/equity ratio of 0.0x indicating zero leverage — a meaningful buffer in uncertain markets. Liquidity also appears solid, with a current ratio of 3.7x, suggesting the company can comfortably cover short-term obligations...
Risk Assessment
- **DATA TRANSPARENCY:** TTM Revenue, TTM Net Income, and Free Cash Flow are all unavailable, preventing a complete fundamental assessment of the business. - **VALUATION PREMIUM:** P/E of 39.12x sits 57% above the sector average of 25x, leaving limited margin of safety if growth disappoints. - **GROWTH BASE EFFECT:** Revenue growth of 1,070% and earnings growth of 3,046% YoY almost certainly reflect expansion from a near-zero base, making these figures highly unlikely to persist and potentially misleading as forward indicators. - **TECHNICALS:** A confirmed "death cross" (50-day MA crossing below 200-day MA) is a bearish momentum signal, and MACD is also bearish, suggesting current price weakness. - **MARGIN ANOMALIES:** Gross margin of 5,585% and net margin of 2,297% are statistically implausible for conventional businesses and suggest either unusual accounting, one-time items, or a very atypical revenue recognition structure — warranting scrutiny. ---...